Merck

Partial coverage
NYSE: MRKUnited StatesPharmaceuticals
Investor relations
DOCUMENTS INDEXED1686 document categories
PRESENTATIONS27Results & investor updates
REPORTING CURRENCYUSDUS dollar

About Merck

Merck researches, develops and markets medicines and vaccines for people around the world. It also develops and sells products for animal health.

Visit investor relations
THE LATEST RESULTS PACKAGE

Q3 2026

Q3 2026

Read the results, explore the slides and follow the discussion.

ISSUER IR DOCUMENT LIBRARY

Explore IR materials 168

Checked 11 Nov 2026
DocumentFormatActions
Q3 2026
Q3 2026 — Press release
Press release·Merck
PDF313 KB
DOCUMENT QUICK VIEW

Q3 2026 — Press release

Q3 2026 — Presentation
Presentation·Merck
PDF2.2 MB
DOCUMENT QUICK VIEW

Q3 2026 — Presentation

PDF304 KB
DOCUMENT QUICK VIEW

Q3 2026 — Prepared remarks

Q3 2026 — Transcript
Transcript·Merck
PDF234 KB
DOCUMENT QUICK VIEW

Q3 2026 — Transcript

PDF1.1 MB
DOCUMENT QUICK VIEW

Q3 2026 — Financial disclosures

Q3 2026 — Quarterly report
Quarterly report·Merck
PDF599 KB
DOCUMENT QUICK VIEW

Q3 2026 — Quarterly report

Q2 2026
Q2 2026 — Press release
Press release·Merck
PDF235 KB
DOCUMENT QUICK VIEW

Q2 2026 — Press release

Q2 2026 — Presentation
Presentation·Merck
PDF2.3 MB
DOCUMENT QUICK VIEW

Q2 2026 — Presentation

Q2 2026 — Transcript
Transcript·Merck
PDF238 KB
DOCUMENT QUICK VIEW

Q2 2026 — Transcript

PDF1.1 MB
DOCUMENT QUICK VIEW

Q2 2026 — Financial disclosures

Q2 2026 — Form 10-Q
Quarterly report·Merck
PDF588 KB
DOCUMENT QUICK VIEW

Q2 2026 — Form 10-Q

Q2 2026 — Quarterly report
Quarterly report·Merck
PDF533 KB
DOCUMENT QUICK VIEW

Q2 2026 — Quarterly report